Students of the Internship Program of the Ministry of Industry and Trade of Russia for the formation of the Youth Personnel Reserve visited FSUE Endopharm. For the third year in a row, the Enterprise becomes a platform where program participants find out how a high-tech domestic production is organized and study models of effective interaction between the state and organizations in the real sector of the economy to achieve the country’s technological sovereignty in the field of medicine provision.
To timely ensure the availability of popular medicines for citizens of the country is one of the priority tasks of the state. The investment projects implemented by the Enterprise together with the Ministry of Industry and Trade of Russia are part of the program on organizing the national security of the country in the field of medicine provision, including the full localization of the strategically important production of narcotic drugs in the Russian Federation to help patients suffering from chronic pain syndrome.
First of all, the visitors got acquainted with the production of sterile injectables and eye drops in vials, lyophilized sterile medicines in vials, as well as sterile medicines in single-dose syringes.
A workshop producing medicines in these forms was reconstructed and technically re-equipped jointly with the Ministry of Industry and Trade of Russia. Denis Manturov, Deputy Prime Minister of the Russian Federation, Minister of Industry and Trade, said that the opening of the workshop was one of the key projects of the pharmaceutical and medical industry in 2020.
When the workshop was opened, it made it possible to double the production capacity of medicines in vials – up to 40 million pieces per year, of lyophilized medicines in glass vials – up to 6.5 million pieces per year, as well as organize production in new dosage forms – in single-dose syringes, with a capacity of 30 million pieces per year.
The reconstruction has become a base for the prompt setting up the production of necessary import-substituting medicines, including those from the group of low molecular weight heparins in single-dose syringes used to prevent thromboembolic complications in the treatment of coronavirus infection. Competent organization of work, professionalism and dedication of FSUE Endopharm’s team, effective interaction with executive authorities allowed the Enterprise to satisfy the demand for the entire range of products during the COVID-19 pandemic, promptly increasing production volumes when demand increased.
Then the visitors studied how the workshop producing sterile medicines in ampoules, one of the few in the Russian Federation that received the international GMP certificate of the European Union, operates. Sophisticated production is organized in accordance with the most stringent domestic and international standards, which allows guaranteeing the high quality of products. Production capacity is up to 140 million ampoules per year.
The product portfolio of the workshop includes more than 40 types of medicines, most of them are included in the list of Vital and Essential Drugs.
In 2022, FSUE Endopharm received a conclusion on compliance with the GMP requirements of the EAEU for the production of veterinary medicinal products, and the workshop began to produce veterinary drugs.
Students studied the principle of designing production facilities, visited the sterile solutions preparation zone, watched the process of preparing, filling, sealing, packaging and labeling of ampoules. An automatic viewing machine was of particular interest of the visitors; this machine carries out 100% control of each unit of production in several parameters with a capacity of up to 24 thousand ampoules per hour.
FSUE Endopharm regularly conducts internships for students of specialized universities in the production and scientific divisions of the Enterprise. Young qualified specialists are a strong support for the successful development of the Enterprise and the Russian economy. During the internship, each student comprehends how he would apply his skills and in what directions he should develop himself in order to get the best results.
To make the younger generation interested in professional realisation in the field of development and production of medicines is of special care of the Enterprise. For this purpose it provides the widest possible opportunities for putting into practice the competencies acquired during the training process.
Comment type is not specified in the component properties.